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Abstract Epistaxis and alcohol overconsumption are
frequently encountered in patients admitted to emergency
wards. The aim of the study was to analyze indirect markers
of alcohol overconsumption in epistaxis patients and eval-
uate its role as a risk factor. In a cohort of 510 epistaxis
patients indirect markers of alcohol overuse were measured
including the mean corpuscular volume (MCV), gamma
glutamyltransferase (GGT), aspartate aminotransferase and
alanine aminotransferase. The results were compared to the
normal findings in literature. Pathologic mean levels of
GGT were found in epistaxis patients. Almost 5% had
macrocytosis and MCV correlated positively with liver
enzyme levels. Platelet counts were negatively correlated
with both corpuscular volumes and liver enzymes. Indirect
markers of alcohol overconsumption were found to be
elevated in epistaxis patients. These results suggest that a
subgroup of epistaxis patients overconsumes alcoholic
beverages supporting the idea of alcohol abuse being a risk
factor in epistaxis. Questioning about drinking habits
should be employed and help offered to affected patients.
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Background
Epistaxis is the most common emergency in rhinology and
accounts for almost 600 consultations at the University
Hospital of Zurich per year [1]. Although the diagnosis
rarely poses a difficulty, its treatment can be quite trou-
blesome and patients often inquire about preventive mea-
sures that could be taken. The identification of risk factors
in epistaxis therefore is essential and different causatives
could be identified including antiaggregational drugs,
anticoagulants and seasonal weather changes [1, 2]. The
misuse of alcohol has been noticed in up to 25% of indi-
viduals admitted to an emergency ward [3]. Alcohol has
not been studied extensively in epistaxis. A prolonged
bleeding time in epistaxis patients with regular alcohol use
was observed, even at low levels of intake [4].
We therefore decided to take a closer look at a possible
influence of alcohol in epistaxis. It is very difficult to
correctly assess alcohol intake in an emergency situation
by a patient’s history and measurement of blood-alcohol
levels not only raises ethical concerns but also does not
reflect long-term use. We therefore decided to use the
routine blood testing that has been collected during a
prospective epistaxis cohort study to measure indirect
markers of alcohol intake [5]. The mean corpuscular vol-
ume (MCV) has been associated with alcohol overuse [6].
Chronic alcohol use was shown to be one of the major
causes of macrocytosis (MCV [ 100 fl) [7]. Sensitivity
and specificity for MCV [ 93 fl measurements predicting
regular heavy drinking were reported to be as high as 73
and 96.7%, respectively [8]. Furthermore, it has been
shown that gamma glutamyltransferase (GGT) and aspar-
tate aminotransferase/alanine aminotransferase (AST/ALT)
were reasonable markers for ethanol consumption when
combined with measurements of MCV [9].
It was the goal of this study to examine blood markers of
chronic alcohol use in a large cohort of epistaxis patients
and to compare it to results from large screenings in the
general population.
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Materials and methods
Patients
Patients presenting at the ENT department of the Univer-
sity Hospital of Zurich for the reason of non-traumatic
epistaxis were included in this study between March 2007
and April 2008. Data collection was performed with the
permission of the local ethical committee and review
board.
Neither the intake of anticoagulants such as warfarin nor
the use of antiaggregational medication such as acetylsal-
icylic acid or clopidogrel were considered exclusion cri-
teria as they were evenly distributed among patients with
elevated indirect markers of alcohol overuse and those with
normal values. Furthermore, the exclusion of these patients
would have lead to a selection of a certain patient sub-
population, which was not the aim of this study as we
wanted to analyze a representative study group. The
parameters used in this study and the corresponding norm-
values can be found in Table 1. None of the patients that
presented repeatedly had pathologic MCV levels at any
visit. The source of bleeding, treatments and complications
were also noted and have been published previously [1].
To classify a patient as having macrocytosis, the cut-off
value of 100 fl was used. For the comparison with a normal
population, the proportions provided in the literature were
used. According to Cohen et al. [10] AST/ALT ratios of
above 2 are almost indicative and[1.5 strongly suggestive
for alcoholic damage of the liver. Therefore, the AST/ALT
ratios were calculated for all patients.
Statistics
Comparison of categorical data was done by the Chi-square
test or Fischer’s exact test. As the data showed a normal
distribution, Student’s t test analyzed differences in cell
counts between groups and the Pearson coefficient was
used in correlation analyses. The significance level alpha
was set to 0.05.
Results
The original study population consisted of 591 bleeding
events in 571 patients [1]. Bleeding sources were evenly
distributed between both sides. In-hospital stay was
required in 17%. One hundred ninety-eight (34%) reported
using ASA therapy, 107 (18%) were on a coumarin treat-
ment and 3% used clopidogrel. Anterior epistaxis was
present in 399 events (68%), whereas 180 (31%) had a
posterior bleeding source. Local cautery was applied in a
total of 493 (84%). Packing with either a Rapid Rhino pack
or using a Foley catheter was performed in 151 (26%) of
events. Surgical therapy was performed by endonasal clo-
sure of the branches of the sphenopalatine artery by
endoscopic surgery in 35 (6%) and 5 (1%) individuals
needed an additional external approach to the ethmoidal
vessels. Complications were observed in 3% of all patients.
Five hundred and fifty-seven peripheral venous blood
samples were obtained during the first emergency visit in a
total of 537 patients. Two hundred thirty-six (44%) female
and 301 (56%) male patients with a mean age of 66.0 years
(min 12 years, max 97 years) were enrolled. Twenty-seven
samples could not be used for all analyses as their blood
sampling was incomplete.
Samples from 510 patients could therefore be used
entirely for the present study. The mean values and stan-
dard error of the mean of the measured blood counts as
well as liver parameters can be found in Table 2. The only
parameter that was found to be abnormal in both sex-
groups was GGT, while MCV levels were within normal
range and distribution. However, looking at macrocytosis
in the studied population, 24 patients (4.7%) revealed
pathologic values of [100 fl. Comparing these with the
cumulative macrocytosis values from literature (480/
16,488; 2.9%) consisting of 1.7% [11], 2.4% [12], 3.0%
[7], 3.7% (cut off 98.5 fl) [13] we observed a significantly
higher incidence (p = 0.03). Twelve of the 24 patients
(50%) had a bleeding source located posteriorly and
Table 1 Normal values of blood markers
Parameter Normal
value
(female)
Normal
value (male)
Hb (g/dl)a 11.7–15.3 13.4–17.0
MCV (fl)a 80–100 80–100
MCH (pg)a 26–34 26–34
MCHC (%)a 31–36 31–36
Thrombocyte count (103/
ll)a
143–400 143–400
GGT (U/l) 5–36 8–61
aP (U/l) \104 \129 (older than 18 years)
\390 (younger than
18 years)
AST (U/l) 10–35 10–50
ALT (U/l) 10–35 10–50
INR 0.8–1.2 0.8–1.2
PTT (s) 25–40 25–40
Hb hemoglobin, MCV mean corpuscular volume, MCH mean cor-
puscular hemoglobin, MCHC mean corpuscular hemoglobin con-
centration, GGT gamma glutamyltransferase, aP alkaline
phosphatase, AST aspartate aminotransferase, ALT alanine amino-
transferase, INR international normalized ratio, PPT partial throm-
boplastin time
a Automated blood count
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required posterior packing for the treatment. On the other
hand, 12 of 153 patients with posterior epistaxis had MCVs
above 100 fl, whereas only 12 of 353 of anterior bleed-
ers suffered from macrocytosis p = 0.04. Of the 24
patients identified of having macrocytosis the MCH was
104.5 ± 0.7 fl. 18 of the 24 (75%) individuals had patho-
logic GGT levels and the AST/ALT ratio was above 1.5 in
12 (50%) and above 2 in 5 (21%), indicating an alcohol-
caused liver dysfunction in this group. No differences in
the proportions of antiaggregational or anticoagulative
medications used nor in the mean values of INR or PTT
were found in the group with a macrocytosis.
Further analyses were performed regarding MCV and
the levels of the liver parameters like GGT, alkaline
phosphatase (aP), AST and ALT. GGT, AST and ALT
positively correlate with the MCV highly significantly,
whereas alkaline phosphatase (aP) does not (p = 0.54).
n = 488 (MCV/GGT), n = 463 (MCV/aP), n = 497
(MCV/AST), n = 494 (MCV/ALT) (Fig. 1). These corre-
lations further strengthen the hypothesis that macrocytosis
is associated with liver dysfunction and potentially with
ethanol intake. GGT were compared in epistaxis patients
having a MCV [ 100 fl (n = 24) or \ 100 fl (n = 465)
showing significantly higher levels in the group with
macrocytosis (Fig. 2a).
To further assess influencing factors (besides drug-
derived platelet dysfunction and decreased coagulation
by vitamin K antagonists) we looked at platelet counts.
A borderline difference was found between the two
groups with (n = 24) and without (n = 488) macrocy-
tosis (227,400 ± 17,300 vs. 262,700 ± 19,900 cells/Ul,
p = 0.08, Fig. 2b). Finally looking at the connection
between the platelet count, the MCV and liver parame-
ters including GGT, AST and ALT, we again found a
significant, but negative correlation of the thrombocyte
number and the different measurements with the excep-
tion of aP (p = 0.14). n = 512 (Tc-count/MCV), n =
488 (Tc-count/GGT), n = 497 (Tc-count/AST), n = 494
(Tc-count/ALT) (Fig. 3).
Table 2 Mean values of blood markers
Male SEM male Female SEM female
Hb (g/dl)a 13.68 0.12 12.75 0.11
MCV (fl)a 90.27 0.40 89.40 0.37
MCH (pg)a 31.47 0.15 30.84 0.14
MCHC (%)a 34.86 0.08 34.48 0.09
Tc-count (103/ll)a 242.1 5.24 284.1 6.07
GGT (U/l) 74.11? 8.56 45.78? 6.07
aP (U/l) 83.96 8.56 83.07 2.61
AST (U/l) 33.39 1.36 29.23 0.99
ALT (U/l) 30.26 1.37 22.92 0.92
INR 1.33? 0.05 1.35? 0.06
PPT (s) 29.97 0.36 30.31 0.48
Hb hemoglobin, MCV mean corpuscular volume, MCH mean cor-
puscular hemoglobin, MCHC mean corpuscular hemoglobin con-
centration, GGT gamma glutamyltransferase, aP alkaline
phosphatase, AST aspartate aminotransferase, ALT alanine amino-
transferase, INR international normalized ratio, PPT partial throm-
boplastin time, SEM standard error of the mean, ? above reference
level
a Automated blood count
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Fig. 1 Mean corpuscular
volume (MCV) positively
correlates with liver enzymes in
epistaxis patients p and r values
from Pearson’s correlation are
provided, where significant
Eur Arch Otorhinolaryngol (2012) 269:1917–1922 1919
123
Discussion
In the current study we investigated indirect markers of
alcohol overconsumption in epistaxis patients including
GGT levels and MCV. We observed a subgroup with
macrocytosis within our cohort of epistaxis patients. Mean
GGT levels were elevated in the whole study population
and liver enzymes positively correlated with MCV, while
platelet counts showed a decrease. All measured parame-
ters suggest that a subgroup of patients suffer from alcohol
overconsumption, supporting the idea of alcohol as a risk
factor in epistaxis [4, 14–16].
GGT is supposed to be the first liver enzyme to be
elevated in alcohol-induced liver damage [17]. Alcohol
causes a wide array of adverse effects on blood cell for-
mation by not yet clearly identified modes of action [18].
There, however, is a dose dependence of ethanol con-
sumption and red blood indices [19].
The MCV has been reported to be a reasonable marker
for chronic alcohol use especially in conjunction with liver
parameters such as GGT [5]. We have identified a signif-
icant number of patients showing high levels of these
markers in a non-selected group of epistaxis patients. MCV
and other indicators have been reported to have a low
sensitivity therefore we might have underestimated the
number of patients with excessive drinking habits. How-
ever, specificity of these tests is higher and therefore the
likelihood of a positively tested patient to truly overcon-
sume alcohol is increasing [8]. We therefore consider MCV
elevation in conjunction with rising levels of hepatic
enzymes in the blood to be indirect markers of excessive
drinking.
Besides the problem when performing a retrospective
study (although using prospectively collected data), there
of course are other factors that need to be considered: we
were unable to address the patient’s history concerning
drinking habits. Different questionnaires have been devel-
oped to correctly assess alcohol overconsumption but their
sensitivity and specificity when used alone are comparable
to laboratory testings [20]. In an emergency situation the
use of long questionnaires might not be the optimal way of
screening [3].
In addition to alcohol overconsumption, there are other
factors that may lead to a rise in liver enzymes and the
corpuscular volume. Macrocytosis may be caused by many
different disorders and agents such as medication, hypo-
thyroidism and vitamin B12 deficiency [21]. The same is
true for liver enzymes where different disorders and med-
ications may cause a rise in levels [22]. A biliary cause can
almost be excluded because of missing correlation of MCV
and thrombocytes with alkaline phosphatase levels [23].
According to the found AST/ALT ratios an ethylic cause of
the liver distress is highly likely.
Posterior bleedings were overrepresented (50%) in the
group with elevated indirect markers of alcohol overuse, in
comparison to the general epistaxis cohort, where posterior
bleedings were reported to be only 31% [1]. Posterior
bleeding usually led to more invasive treatments than
anteriorly located ones and therefore poses a greater burden
on the patient. Alcohol is already known to interfere with
coagulation, thrombocyte function and fibrinolysis [24,
25]. Despite the fact that coagulopathies, thrombocyte
dysfunction and alcohol lead to epistaxis, they were shown
to be associated with posterior and severe bleedings [1, 14].
In our work posterior epistaxis was significantly associated
with macrocytosis which is similar to the association of
posterior and heavy bleedings in patients with aspirin
intake [1]. We postulate that macrocytosis as a marker of
alcohol overuse in epistaxis patients points to those indi-
viduals with an alcohol-induced hemostatic disorder,
leading to more severe bleedings.
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Fig. 2 GGT is elevated and platelet count is lower in epistaxis
patients with macrocytosis results from Student’s t test provided
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In conclusion, we observed that epistaxis patients suffer
from macrocytosis in a larger proportion than found in the
general population. Along with an increase of the eryth-
rocyte volume an increase in other parameters suggestive
of chronic alcohol intake could be shown. These findings
support the idea that alcohol plays a role as a risk factor
especially in posterior epistaxis. The results of this study
justify further direct investigations of alcohol consumption
in this patient cohort. Questioning about drinking habits
should be employed in everyday practice when treating
epistaxis patients and appropriate help needs to be offered
to the affected patients.
Conflict of interest None.
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